nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2E1—Parkinson's disease	0.5	0.577	CbGaD
Methazolamide—CYP2D6—Parkinson's disease	0.367	0.423	CbGaD
Methazolamide—CA1—nerve—Parkinson's disease	0.00318	0.052	CbGeAlD
Methazolamide—CA4—nerve—Parkinson's disease	0.00249	0.0407	CbGeAlD
Methazolamide—CA4—hindbrain—Parkinson's disease	0.00186	0.0304	CbGeAlD
Methazolamide—CA7—midbrain—Parkinson's disease	0.00169	0.0276	CbGeAlD
Methazolamide—CA12—forebrain—Parkinson's disease	0.00166	0.0272	CbGeAlD
Methazolamide—CA2—hindbrain—Parkinson's disease	0.00155	0.0252	CbGeAlD
Methazolamide—CA14—medulla oblongata—Parkinson's disease	0.00154	0.0252	CbGeAlD
Methazolamide—CA6—head—Parkinson's disease	0.00142	0.0232	CbGeAlD
Methazolamide—CA14—midbrain—Parkinson's disease	0.00141	0.023	CbGeAlD
Methazolamide—CA14—spinal cord—Parkinson's disease	0.00138	0.0225	CbGeAlD
Methazolamide—CA1—forebrain—Parkinson's disease	0.00132	0.0215	CbGeAlD
Methazolamide—CA7—cerebellum—Parkinson's disease	0.00131	0.0214	CbGeAlD
Methazolamide—CA5B—cardiovascular system—Parkinson's disease	0.00126	0.0206	CbGeAlD
Methazolamide—CA9—cerebellum—Parkinson's disease	0.00115	0.0188	CbGeAlD
Methazolamide—CA1—cardiovascular system—Parkinson's disease	0.00112	0.0182	CbGeAlD
Methazolamide—CA14—cerebellum—Parkinson's disease	0.00109	0.0178	CbGeAlD
Methazolamide—CA4—brainstem—Parkinson's disease	0.00107	0.0175	CbGeAlD
Methazolamide—CA7—brain—Parkinson's disease	0.00106	0.0174	CbGeAlD
Methazolamide—CA4—forebrain—Parkinson's disease	0.00103	0.0168	CbGeAlD
Methazolamide—CYP2D6—hindbrain—Parkinson's disease	0.000981	0.016	CbGeAlD
Methazolamide—CA2—embryo—Parkinson's disease	0.000966	0.0158	CbGeAlD
Methazolamide—CA12—head—Parkinson's disease	0.000953	0.0156	CbGeAlD
Methazolamide—CA12—nervous system—Parkinson's disease	0.000904	0.0148	CbGeAlD
Methazolamide—CA14—brain—Parkinson's disease	0.000886	0.0145	CbGeAlD
Methazolamide—CA2—brainstem—Parkinson's disease	0.000886	0.0145	CbGeAlD
Methazolamide—CA4—cardiovascular system—Parkinson's disease	0.000872	0.0142	CbGeAlD
Methazolamide—CA12—central nervous system—Parkinson's disease	0.00087	0.0142	CbGeAlD
Methazolamide—CA5B—head—Parkinson's disease	0.000855	0.014	CbGeAlD
Methazolamide—CA2—forebrain—Parkinson's disease	0.000855	0.014	CbGeAlD
Methazolamide—CA1—spinal cord—Parkinson's disease	0.00085	0.0139	CbGeAlD
Methazolamide—CA5B—nervous system—Parkinson's disease	0.000811	0.0132	CbGeAlD
Methazolamide—CA5B—central nervous system—Parkinson's disease	0.000781	0.0128	CbGeAlD
Methazolamide—SLC22A6—brain—Parkinson's disease	0.000771	0.0126	CbGeAlD
Methazolamide—CA1—head—Parkinson's disease	0.000755	0.0123	CbGeAlD
Methazolamide—CA4—medulla oblongata—Parkinson's disease	0.000745	0.0122	CbGeAlD
Methazolamide—CA2—cardiovascular system—Parkinson's disease	0.000723	0.0118	CbGeAlD
Methazolamide—CA1—nervous system—Parkinson's disease	0.000716	0.0117	CbGeAlD
Methazolamide—CA12—brain—Parkinson's disease	0.000691	0.0113	CbGeAlD
Methazolamide—CA1—central nervous system—Parkinson's disease	0.000689	0.0113	CbGeAlD
Methazolamide—CA4—midbrain—Parkinson's disease	0.000681	0.0111	CbGeAlD
Methazolamide—CA4—spinal cord—Parkinson's disease	0.000664	0.0109	CbGeAlD
Methazolamide—CA5B—brain—Parkinson's disease	0.00062	0.0101	CbGeAlD
Methazolamide—CA2—medulla oblongata—Parkinson's disease	0.000618	0.0101	CbGeAlD
Methazolamide—CYP2C9—cardiovascular system—Parkinson's disease	0.000611	0.00999	CbGeAlD
Methazolamide—CA4—head—Parkinson's disease	0.00059	0.00964	CbGeAlD
Methazolamide—CYP2E1—cardiovascular system—Parkinson's disease	0.000579	0.00947	CbGeAlD
Methazolamide—CA2—midbrain—Parkinson's disease	0.000564	0.00922	CbGeAlD
Methazolamide—CYP2D6—brainstem—Parkinson's disease	0.000562	0.00919	CbGeAlD
Methazolamide—CA4—nervous system—Parkinson's disease	0.00056	0.00914	CbGeAlD
Methazolamide—CA2—spinal cord—Parkinson's disease	0.000551	0.009	CbGeAlD
Methazolamide—CA1—brain—Parkinson's disease	0.000547	0.00894	CbGeAlD
Methazolamide—CYP2D6—forebrain—Parkinson's disease	0.000543	0.00887	CbGeAlD
Methazolamide—CA4—central nervous system—Parkinson's disease	0.000539	0.0088	CbGeAlD
Methazolamide—CA4—cerebellum—Parkinson's disease	0.000527	0.0086	CbGeAlD
Methazolamide—CYP2E1—medulla oblongata—Parkinson's disease	0.000495	0.00809	CbGeAlD
Methazolamide—CA2—head—Parkinson's disease	0.000489	0.008	CbGeAlD
Methazolamide—CA2—nervous system—Parkinson's disease	0.000464	0.00758	CbGeAlD
Methazolamide—CA2—central nervous system—Parkinson's disease	0.000447	0.0073	CbGeAlD
Methazolamide—CYP2E1—spinal cord—Parkinson's disease	0.000442	0.00721	CbGeAlD
Methazolamide—CA2—cerebellum—Parkinson's disease	0.000437	0.00713	CbGeAlD
Methazolamide—CA4—brain—Parkinson's disease	0.000428	0.00699	CbGeAlD
Methazolamide—CYP2E1—head—Parkinson's disease	0.000392	0.00641	CbGeAlD
Methazolamide—CYP2E1—nervous system—Parkinson's disease	0.000372	0.00608	CbGeAlD
Methazolamide—CYP2E1—central nervous system—Parkinson's disease	0.000358	0.00585	CbGeAlD
Methazolamide—CA2—brain—Parkinson's disease	0.000355	0.00579	CbGeAlD
Methazolamide—CYP2E1—cerebellum—Parkinson's disease	0.00035	0.00572	CbGeAlD
Methazolamide—CYP2D6—head—Parkinson's disease	0.000311	0.00508	CbGeAlD
Methazolamide—CYP3A4—nervous system—Parkinson's disease	0.000299	0.00489	CbGeAlD
Methazolamide—CYP2D6—nervous system—Parkinson's disease	0.000295	0.00481	CbGeAlD
Methazolamide—CYP3A4—central nervous system—Parkinson's disease	0.000288	0.00471	CbGeAlD
Methazolamide—CYP2E1—brain—Parkinson's disease	0.000284	0.00465	CbGeAlD
Methazolamide—CYP2D6—central nervous system—Parkinson's disease	0.000284	0.00463	CbGeAlD
Methazolamide—CYP2D6—cerebellum—Parkinson's disease	0.000277	0.00453	CbGeAlD
Methazolamide—CYP2D6—brain—Parkinson's disease	0.000225	0.00368	CbGeAlD
Methazolamide—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	5.41e-05	0.000759	CbGpPWpGaD
Methazolamide—CA7—Metabolism—GPX1—Parkinson's disease	5.39e-05	0.000756	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—GPX1—Parkinson's disease	5.39e-05	0.000756	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	5.39e-05	0.000755	CbGpPWpGaD
Methazolamide—CA12—Metabolism—ABCB1—Parkinson's disease	5.38e-05	0.000753	CbGpPWpGaD
Methazolamide—CA4—Metabolism—TH—Parkinson's disease	5.35e-05	0.00075	CbGpPWpGaD
Methazolamide—CA6—Metabolism—MTHFR—Parkinson's disease	5.33e-05	0.000747	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—MTHFR—Parkinson's disease	5.33e-05	0.000747	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	5.32e-05	0.000745	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYP2E1—Parkinson's disease	5.27e-05	0.000738	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GSTM1—Parkinson's disease	5.22e-05	0.000731	CbGpPWpGaD
Methazolamide—CA2—Metabolism—NQO1—Parkinson's disease	5.21e-05	0.00073	CbGpPWpGaD
Methazolamide—CA4—Metabolism—CYCS—Parkinson's disease	5.14e-05	0.00072	CbGpPWpGaD
Methazolamide—CA2—Metabolism—TH—Parkinson's disease	5.13e-05	0.000719	CbGpPWpGaD
Methazolamide—CA14—Metabolism—APOE—Parkinson's disease	5.09e-05	0.000714	CbGpPWpGaD
Methazolamide—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	5.06e-05	0.00071	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ND3—Parkinson's disease	5.06e-05	0.000709	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MCCC1—Parkinson's disease	5.06e-05	0.000709	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYP2E1—Parkinson's disease	5.05e-05	0.000707	CbGpPWpGaD
Methazolamide—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	5.02e-05	0.000704	CbGpPWpGaD
Methazolamide—CA12—Metabolism—GPX1—Parkinson's disease	5e-05	0.0007	CbGpPWpGaD
Methazolamide—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	4.99e-05	0.0007	CbGpPWpGaD
Methazolamide—CA1—Metabolism—NQO1—Parkinson's disease	4.99e-05	0.0007	CbGpPWpGaD
Methazolamide—CA7—Metabolism—MTHFR—Parkinson's disease	4.98e-05	0.000698	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—MTHFR—Parkinson's disease	4.98e-05	0.000698	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—APOE—Parkinson's disease	4.96e-05	0.000696	CbGpPWpGaD
Methazolamide—CA6—Metabolism—APOE—Parkinson's disease	4.96e-05	0.000696	CbGpPWpGaD
Methazolamide—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	4.95e-05	0.000694	CbGpPWpGaD
Methazolamide—CA2—Metabolism—CYCS—Parkinson's disease	4.93e-05	0.00069	CbGpPWpGaD
Methazolamide—CA1—Metabolism—TH—Parkinson's disease	4.92e-05	0.000689	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP2D6—Parkinson's disease	4.85e-05	0.00068	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	4.78e-05	0.000669	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CTGF—Parkinson's disease	4.76e-05	0.000667	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TALDO1—Parkinson's disease	4.76e-05	0.000667	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—OMD—Parkinson's disease	4.76e-05	0.000667	CbGpPWpGaD
Methazolamide—CA1—Metabolism—CYCS—Parkinson's disease	4.72e-05	0.000662	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	4.71e-05	0.00066	CbGpPWpGaD
Methazolamide—CA7—Metabolism—APOE—Parkinson's disease	4.64e-05	0.00065	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—APOE—Parkinson's disease	4.64e-05	0.00065	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	4.62e-05	0.000648	CbGpPWpGaD
Methazolamide—CA12—Metabolism—MTHFR—Parkinson's disease	4.61e-05	0.000646	CbGpPWpGaD
Methazolamide—CA4—Metabolism—COMT—Parkinson's disease	4.55e-05	0.000638	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTP1—Parkinson's disease	4.53e-05	0.000635	CbGpPWpGaD
Methazolamide—CA4—Metabolism—MAOA—Parkinson's disease	4.52e-05	0.000633	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	4.51e-05	0.000632	CbGpPWpGaD
Methazolamide—CA4—Metabolism—HMOX1—Parkinson's disease	4.47e-05	0.000626	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYP2E1—Parkinson's disease	4.44e-05	0.000622	CbGpPWpGaD
Methazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	4.44e-05	0.000622	CbGpPWpGaD
Methazolamide—CA9—Metabolism—NQO1—Parkinson's disease	4.39e-05	0.000615	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	4.37e-05	0.000612	CbGpPWpGaD
Methazolamide—CA2—Metabolism—COMT—Parkinson's disease	4.36e-05	0.000611	CbGpPWpGaD
Methazolamide—CA14—Metabolism—INS—Parkinson's disease	4.35e-05	0.00061	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTP1—Parkinson's disease	4.34e-05	0.000609	CbGpPWpGaD
Methazolamide—CA2—Metabolism—MAOA—Parkinson's disease	4.33e-05	0.000607	CbGpPWpGaD
Methazolamide—CA9—Metabolism—TH—Parkinson's disease	4.32e-05	0.000606	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	4.31e-05	0.000604	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GCH1—Parkinson's disease	4.3e-05	0.000603	CbGpPWpGaD
Methazolamide—CA12—Metabolism—APOE—Parkinson's disease	4.29e-05	0.000602	CbGpPWpGaD
Methazolamide—CA9—Cellular responses to stress—IL6—Parkinson's disease	4.29e-05	0.000601	CbGpPWpGaD
Methazolamide—CA4—Metabolism—ABCB1—Parkinson's disease	4.29e-05	0.000601	CbGpPWpGaD
Methazolamide—CA2—Metabolism—HMOX1—Parkinson's disease	4.28e-05	0.0006	CbGpPWpGaD
Methazolamide—CA6—Metabolism—INS—Parkinson's disease	4.24e-05	0.000594	CbGpPWpGaD
Methazolamide—CA5A—Metabolism—INS—Parkinson's disease	4.24e-05	0.000594	CbGpPWpGaD
Methazolamide—CA1—Metabolism—COMT—Parkinson's disease	4.18e-05	0.000586	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTP1—Parkinson's disease	4.16e-05	0.000583	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GSTM1—Parkinson's disease	4.16e-05	0.000583	CbGpPWpGaD
Methazolamide—CA1—Metabolism—MAOA—Parkinson's disease	4.15e-05	0.000582	CbGpPWpGaD
Methazolamide—CA9—Metabolism—CYCS—Parkinson's disease	4.15e-05	0.000582	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.15e-05	0.000581	CbGpPWpGaD
Methazolamide—CA2—Metabolism—ABCB1—Parkinson's disease	4.11e-05	0.000576	CbGpPWpGaD
Methazolamide—CA1—Metabolism—HMOX1—Parkinson's disease	4.11e-05	0.000575	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GSTM1—Parkinson's disease	3.99e-05	0.000559	CbGpPWpGaD
Methazolamide—CA4—Metabolism—GPX1—Parkinson's disease	3.99e-05	0.000559	CbGpPWpGaD
Methazolamide—CA5B—Metabolism—INS—Parkinson's disease	3.96e-05	0.000555	CbGpPWpGaD
Methazolamide—CA7—Metabolism—INS—Parkinson's disease	3.96e-05	0.000555	CbGpPWpGaD
Methazolamide—CA1—Metabolism—ABCB1—Parkinson's disease	3.94e-05	0.000552	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ND3—Parkinson's disease	3.9e-05	0.000547	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MCCC1—Parkinson's disease	3.9e-05	0.000547	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—FBP1—Parkinson's disease	3.83e-05	0.000537	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—DBH—Parkinson's disease	3.83e-05	0.000537	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GBA—Parkinson's disease	3.83e-05	0.000537	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GSTM1—Parkinson's disease	3.83e-05	0.000536	CbGpPWpGaD
Methazolamide—CA2—Metabolism—GPX1—Parkinson's disease	3.82e-05	0.000536	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	3.78e-05	0.00053	CbGpPWpGaD
Methazolamide—CA4—Metabolism—MTHFR—Parkinson's disease	3.68e-05	0.000515	CbGpPWpGaD
Methazolamide—CA9—Metabolism—COMT—Parkinson's disease	3.68e-05	0.000515	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—OMD—Parkinson's disease	3.67e-05	0.000514	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TALDO1—Parkinson's disease	3.67e-05	0.000514	CbGpPWpGaD
Methazolamide—CA12—Metabolism—INS—Parkinson's disease	3.67e-05	0.000514	CbGpPWpGaD
Methazolamide—CA1—Metabolism—GPX1—Parkinson's disease	3.66e-05	0.000513	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTP1—Parkinson's disease	3.66e-05	0.000513	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MAOA—Parkinson's disease	3.65e-05	0.000512	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—COMT—Parkinson's disease	3.62e-05	0.000507	CbGpPWpGaD
Methazolamide—CA9—Metabolism—HMOX1—Parkinson's disease	3.61e-05	0.000506	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	3.6e-05	0.000505	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	3.59e-05	0.000504	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MCCC1—Parkinson's disease	3.59e-05	0.000503	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ND3—Parkinson's disease	3.59e-05	0.000503	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	3.57e-05	0.0005	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ND3—Parkinson's disease	3.56e-05	0.000499	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MCCC1—Parkinson's disease	3.56e-05	0.000499	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	3.55e-05	0.000498	CbGpPWpGaD
Methazolamide—CA2—Metabolism—MTHFR—Parkinson's disease	3.53e-05	0.000494	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NDUFB11—Parkinson's disease	3.48e-05	0.000488	CbGpPWpGaD
Methazolamide—CA9—Metabolism—ABCB1—Parkinson's disease	3.46e-05	0.000486	CbGpPWpGaD
Methazolamide—CA4—Metabolism—APOE—Parkinson's disease	3.42e-05	0.00048	CbGpPWpGaD
Methazolamide—CA1—Metabolism—MTHFR—Parkinson's disease	3.38e-05	0.000474	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TALDO1—Parkinson's disease	3.38e-05	0.000473	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—OMD—Parkinson's disease	3.38e-05	0.000473	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GSTM1—Parkinson's disease	3.36e-05	0.000471	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TALDO1—Parkinson's disease	3.35e-05	0.000469	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—OMD—Parkinson's disease	3.35e-05	0.000469	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GCH1—Parkinson's disease	3.32e-05	0.000465	CbGpPWpGaD
Methazolamide—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	3.31e-05	0.000464	CbGpPWpGaD
Methazolamide—CA2—Metabolism—APOE—Parkinson's disease	3.28e-05	0.00046	CbGpPWpGaD
Methazolamide—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	3.27e-05	0.000458	CbGpPWpGaD
Methazolamide—CA9—Metabolism—GPX1—Parkinson's disease	3.22e-05	0.000451	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	3.2e-05	0.000448	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	3.17e-05	0.000445	CbGpPWpGaD
Methazolamide—CA1—Metabolism—APOE—Parkinson's disease	3.15e-05	0.000441	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GCH1—Parkinson's disease	3.05e-05	0.000428	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GCH1—Parkinson's disease	3.03e-05	0.000424	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.99e-05	0.00042	CbGpPWpGaD
Methazolamide—CA9—Metabolism—MTHFR—Parkinson's disease	2.97e-05	0.000417	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—FBP1—Parkinson's disease	2.96e-05	0.000415	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GBA—Parkinson's disease	2.96e-05	0.000415	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—DBH—Parkinson's disease	2.96e-05	0.000415	CbGpPWpGaD
Methazolamide—CA4—Metabolism—INS—Parkinson's disease	2.93e-05	0.00041	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—DDC—Parkinson's disease	2.81e-05	0.000394	CbGpPWpGaD
Methazolamide—CA2—Metabolism—INS—Parkinson's disease	2.8e-05	0.000393	CbGpPWpGaD
Methazolamide—CA9—Metabolism—APOE—Parkinson's disease	2.77e-05	0.000388	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	2.73e-05	0.000383	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GBA—Parkinson's disease	2.72e-05	0.000381	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—DBH—Parkinson's disease	2.72e-05	0.000381	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—FBP1—Parkinson's disease	2.72e-05	0.000381	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GBA—Parkinson's disease	2.7e-05	0.000378	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—FBP1—Parkinson's disease	2.7e-05	0.000378	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—DBH—Parkinson's disease	2.7e-05	0.000378	CbGpPWpGaD
Methazolamide—CA1—Metabolism—INS—Parkinson's disease	2.69e-05	0.000377	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTA4—Parkinson's disease	2.66e-05	0.000372	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	2.39e-05	0.000335	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MAOB—Parkinson's disease	2.37e-05	0.000332	CbGpPWpGaD
Methazolamide—CA9—Metabolism—INS—Parkinson's disease	2.36e-05	0.000331	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MCCC1—Parkinson's disease	2.35e-05	0.000329	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ND3—Parkinson's disease	2.35e-05	0.000329	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TALDO1—Parkinson's disease	2.21e-05	0.000309	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—OMD—Parkinson's disease	2.21e-05	0.000309	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—DDC—Parkinson's disease	2.17e-05	0.000304	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	2.09e-05	0.000293	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTA4—Parkinson's disease	2.05e-05	0.000287	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.02e-05	0.000284	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—DDC—Parkinson's disease	2e-05	0.00028	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GCH1—Parkinson's disease	2e-05	0.00028	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—DDC—Parkinson's disease	1.98e-05	0.000277	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.89e-05	0.000264	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTA4—Parkinson's disease	1.87e-05	0.000262	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—PLA2G6—Parkinson's disease	1.85e-05	0.000259	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	1.85e-05	0.000259	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MAOB—Parkinson's disease	1.83e-05	0.000256	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.78e-05	0.000249	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GBA—Parkinson's disease	1.78e-05	0.000249	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—DBH—Parkinson's disease	1.78e-05	0.000249	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	1.76e-05	0.000247	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.74e-05	0.000244	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CTGF—Parkinson's disease	1.73e-05	0.000242	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	1.7e-05	0.000238	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	1.68e-05	0.000236	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MAOB—Parkinson's disease	1.68e-05	0.000236	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MAOB—Parkinson's disease	1.67e-05	0.000234	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—NQO1—Parkinson's disease	1.59e-05	0.000223	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	1.59e-05	0.000222	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—TH—Parkinson's disease	1.57e-05	0.00022	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—CYCS—Parkinson's disease	1.51e-05	0.000211	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2D6—Parkinson's disease	1.36e-05	0.00019	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—COMT—Parkinson's disease	1.33e-05	0.000187	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CTGF—Parkinson's disease	1.33e-05	0.000187	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTP1—Parkinson's disease	1.33e-05	0.000186	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MAOA—Parkinson's disease	1.32e-05	0.000186	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—HMOX1—Parkinson's disease	1.31e-05	0.000184	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—DDC—Parkinson's disease	1.31e-05	0.000183	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—ABCB1—Parkinson's disease	1.26e-05	0.000176	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYP2E1—Parkinson's disease	1.24e-05	0.000174	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	1.24e-05	0.000174	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTA4—Parkinson's disease	1.23e-05	0.000173	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—NQO1—Parkinson's disease	1.23e-05	0.000172	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CTGF—Parkinson's disease	1.23e-05	0.000172	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GSTM1—Parkinson's disease	1.22e-05	0.000171	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CTGF—Parkinson's disease	1.22e-05	0.00017	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—TH—Parkinson's disease	1.21e-05	0.00017	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—GPX1—Parkinson's disease	1.17e-05	0.000164	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—CYCS—Parkinson's disease	1.16e-05	0.000163	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.14e-05	0.00016	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	1.13e-05	0.000159	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.13e-05	0.000158	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—NQO1—Parkinson's disease	1.12e-05	0.000157	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—TH—Parkinson's disease	1.11e-05	0.000156	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.11e-05	0.000156	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—TH—Parkinson's disease	1.1e-05	0.000155	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.1e-05	0.000154	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.08e-05	0.000151	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.07e-05	0.00015	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.06e-05	0.000149	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—COMT—Parkinson's disease	1.03e-05	0.000144	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTP1—Parkinson's disease	1.02e-05	0.000144	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MAOA—Parkinson's disease	1.02e-05	0.000143	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—HMOX1—Parkinson's disease	1.01e-05	0.000142	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—APOE—Parkinson's disease	1e-05	0.000141	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—ABCB1—Parkinson's disease	9.7e-06	0.000136	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—COMT—Parkinson's disease	9.47e-06	0.000133	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTP1—Parkinson's disease	9.42e-06	0.000132	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GSTM1—Parkinson's disease	9.41e-06	0.000132	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MAOA—Parkinson's disease	9.4e-06	0.000132	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—COMT—Parkinson's disease	9.39e-06	0.000132	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTP1—Parkinson's disease	9.34e-06	0.000131	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MAOA—Parkinson's disease	9.32e-06	0.000131	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—HMOX1—Parkinson's disease	9.29e-06	0.00013	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—HMOX1—Parkinson's disease	9.21e-06	0.000129	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—GPX1—Parkinson's disease	9.02e-06	0.000126	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—ABCB1—Parkinson's disease	8.92e-06	0.000125	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—ABCB1—Parkinson's disease	8.84e-06	0.000124	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GSTM1—Parkinson's disease	8.66e-06	0.000121	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GSTM1—Parkinson's disease	8.58e-06	0.00012	CbGpPWpGaD
Methazolamide—CYP2E1—Metabolism—INS—Parkinson's disease	8.58e-06	0.00012	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—MTHFR—Parkinson's disease	8.32e-06	0.000117	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—GPX1—Parkinson's disease	8.29e-06	0.000116	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—GPX1—Parkinson's disease	8.22e-06	0.000115	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	8.17e-06	0.000114	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CTGF—Parkinson's disease	8.02e-06	0.000112	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—APOE—Parkinson's disease	7.75e-06	0.000109	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—MTHFR—Parkinson's disease	7.65e-06	0.000107	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—MTHFR—Parkinson's disease	7.59e-06	0.000106	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	7.47e-06	0.000105	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—NQO1—Parkinson's disease	7.39e-06	0.000104	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—TH—Parkinson's disease	7.28e-06	0.000102	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—APOE—Parkinson's disease	7.12e-06	9.99e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—APOE—Parkinson's disease	7.06e-06	9.9e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—CYCS—Parkinson's disease	6.99e-06	9.8e-05	CbGpPWpGaD
Methazolamide—CYP2C19—Metabolism—INS—Parkinson's disease	6.62e-06	9.27e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—COMT—Parkinson's disease	6.19e-06	8.68e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTP1—Parkinson's disease	6.16e-06	8.63e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MAOA—Parkinson's disease	6.15e-06	8.61e-05	CbGpPWpGaD
Methazolamide—CYP2D6—Metabolism—INS—Parkinson's disease	6.09e-06	8.53e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—HMOX1—Parkinson's disease	6.08e-06	8.52e-05	CbGpPWpGaD
Methazolamide—CYP2C9—Metabolism—INS—Parkinson's disease	6.03e-06	8.46e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—ABCB1—Parkinson's disease	5.83e-06	8.17e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GSTM1—Parkinson's disease	5.66e-06	7.93e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—GPX1—Parkinson's disease	5.42e-06	7.6e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—MTHFR—Parkinson's disease	5e-06	7.01e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—APOE—Parkinson's disease	4.66e-06	6.53e-05	CbGpPWpGaD
Methazolamide—CYP3A4—Metabolism—INS—Parkinson's disease	3.98e-06	5.58e-05	CbGpPWpGaD
